Vivia Company Profile

Background

Overview

Vivia is a multifaceted company operating in various sectors, including home care services, biotechnology, and consumer products. Each division of Vivia is dedicated to enhancing quality of life through innovative solutions tailored to their respective industries.

Mission and Vision

Vivia's mission is to provide personalized, efficient, and compassionate services and products that cater to the unique needs of individuals, fostering independence, health, and well-being. The company's vision is to be a leader in each of its sectors, driving positive change and setting new standards of excellence.

Primary Areas of Focus

Home Care Services: Offering personalized in-home care solutions for seniors, emphasizing independence and quality of life.

Biotechnology: Developing precision medicine solutions to improve patient outcomes, particularly in oncology.

Consumer Products: Creating innovative products that address specific health and wellness needs.

Industry Significance

Vivia's diverse operations position it as a significant player in enhancing healthcare delivery, advancing medical research, and improving consumer health and wellness.

Key Strategic Focus

Core Objectives

Home Care Services: To revolutionize in-home care by integrating technology with compassionate services, enabling seniors to live independently and comfortably.

Biotechnology: To pioneer precision medicine approaches, providing personalized treatment options that improve patient outcomes.

Consumer Products: To develop and market products that effectively address specific health concerns, enhancing quality of life for consumers.

Areas of Specialization

Home Care Services: Technology-enabled neighborhood models for senior care.

Biotechnology: Ex vivo drug profiling and precision medicine diagnostics.

Consumer Products: Bioidentical hormone therapies for women's health.

Key Technologies Utilized

Home Care Services: Proprietary software platforms and mobile applications for caregiver coordination and service delivery.

Biotechnology: PharmaFlow Technology Platform for drug profiling and precision medicine diagnostics.

Consumer Products: Bioidentical estriol formulations for targeted relief of menopausal symptoms.

Primary Markets Targeted

Home Care Services: Seniors requiring in-home care, initially in Hawaii and the Pacific Northwest.

Biotechnology: Oncology patients, particularly those with hematological malignancies.

Consumer Products: Women experiencing menopausal symptoms, focusing on vaginal health.

Financials and Funding

Funding History

Home Care Services: Recognized as one of Hawaii's Fastest Growing Companies in 2022.

Biotechnology: Secured €7.2 million in a second round of financing in 2012, led by Bioanalítica Inversiones SL.

Consumer Products: Specific funding details are not publicly disclosed.

Utilization of Capital

Home Care Services: Expansion of service areas and enhancement of technological infrastructure.

Biotechnology: Advancement of precision medicine diagnostics and drug profiling technologies.

Consumer Products: Product development, clinical studies, and marketing initiatives.

Pipeline Development

Home Care Services

Expansion: Opened a new office in Olympia, Washington, in February 2025, marking the entry into the Pacific Northwest market.

Biotechnology

PharmaFlow PM: A precision medicine test for hematological malignancies, aiming to identify optimal treatment options for individual patients.

Consumer Products

Intimate Bloom Protocol: A bioidentical estriol-based product designed to restore vaginal tissue health and alleviate menopausal symptoms.

Technological Platform and Innovation

Proprietary Technologies

Home Care Services: Proprietary software and mobile app platforms that facilitate caregiver coordination, service delivery, and family communication.

Biotechnology: PharmaFlow Technology Platform for comprehensive ex vivo drug profiling and precision medicine diagnostics.

Significant Scientific Methods

Home Care Services: Integration of technology with in-home care services to enhance efficiency and personalization.

Biotechnology: Ex vivo testing that preserves the native environment of cell populations, enabling accurate drug profiling.

AI-Driven Capabilities

Biotechnology: Utilization of advanced data analysis and modeling techniques to interpret complex biological data and inform treatment decisions.

Leadership Team

Home Care Services

Dew-Anne Langcaon: CEO of Vivia Cares, leading the expansion and innovation of home care services.

Biotechnology

Andrés Ballesteros: CEO of Vivia Biotech, overseeing the development of precision medicine solutions.

Joan Ballesteros: Chairman & CSO of Vivia Biotech, contributing to strategic direction and scientific innovation.

Joaquín Martínez: Medical Director of Vivia Biotech, leading clinical and medical affairs.

Consumer Products

Dr. Umair Khalid: Founder of Vivia, leading the development of bioidentical hormone therapies.

Dr. Linda Raeisi: Clinical Lead at Vivia, overseeing product development and clinical studies.

Market Insights and Dynamics

Home Care Services: The in-home care market is experiencing growth due to an aging population and a preference for aging in place.

Biotechnology: Precision medicine is a rapidly evolving field, with increasing demand for personalized treatment options.

Consumer Products: There is a growing market for women's health products addressing menopausal symptoms, driven by increased awareness and demand for natural solutions.

Competitor Analysis

Home Care Services: Competitors include traditional home care agencies and emerging tech-enabled care models.

Biotechnology: Competes with other precision medicine companies and diagnostic firms focusing on personalized oncology treatments.

Consumer Products: Faces competition from established pharmaceutical companies and new entrants offering similar health products.

Strategic Collaborations and Partnerships

Home Care Services

Above Home Health: Collaborated to integrate the Vivia model, enhancing service delivery and caregiver satisfaction.

Biotechnology

Pharmaceutical Partnerships: Engages with pharmaceutical companies to provide precision medicine capabilities for drug development and biomarker discovery.

Consumer Products

Healthcare Professionals: Collaborates with gynecologists and women's health experts to develop and recommend products.

Operational Insights

Strategic Considerations

Home Care Services: Focuses on integrating technology to improve service efficiency and caregiver satisfaction, differentiating itself from traditional models.